Fluorodeoxiglucose (FDG)-avidity at positron emission computed tomography/computed tomography (PET/CT) during adjuvant hormonal therapy (HT) in breast cancer (BC) patients

Autor: Redana, S, Gucalp, A, Ghiotto, C, Vinante, L, Zago, G, Fornier, Mn, Evangelista, L

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______3657::b94325fac7ac58908eb1e6127aec6505
http://hdl.handle.net/11577/3312734

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Ixabepilone, first in a new class of antineoplastic agents: the natural epothilones and their analogues.

Autor: Fornier MN

Publikováno v: Clinical Cancer Update; Dec2007, Vol. 1 Issue 1, p9-15, 7p

Oral minoxidil for late alopecia in cancer survivors.

Autor: Kuo AM; Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Reingold RE; Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Ketosugbo KF; Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Pan A; Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Kraehenbuehl L; Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Ludwig Collaborative and Swim Across America Laboratory, Human Oncology and Pathogenesis Program, Department of Medicine, MSKCC, Parker Institute for Cancer Immunotherapy, New York, NY, USA., Dusza S; Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Gajria D; Breast Medicine Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Lake DE; Breast Medicine Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Bromberg JF; Breast Medicine Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Traina TA; Breast Medicine Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Fornier MN; Breast Medicine Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Gucalp A; Breast Medicine Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., D'Alessandro BM; Canfield Scientific, Inc., Parsippany, NJ, USA., Rotemberg V; Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Dauscher M; Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Shapiro J; Ronald O. Perelman Department of Dermatology, NYU Grossman School of Medicine, New York, NY, USA., Goldfarb SB; Breast Medicine Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Markova A; Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Lacouture ME; Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. Mario.Lacouture@nyulangone.org.; Dermatology Division, Department of Medicine, NYU Grossman Long Island School of Medicine, Mineola, New York, USA. Mario.Lacouture@nyulangone.org.; Symptom Management Program, Perlmutter Cancer Center, NYU Langone Hospital - Long Island, Mineola, New York, USA. Mario.Lacouture@nyulangone.org.

Publikováno v: Breast cancer research and treatment [Breast Cancer Res Treat] 2024 Dec; Vol. 208 (3), pp. 491-499. Date of Electronic Publication: 2024 Aug 04.